These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25629310)

  • 1. Recent developments in therapeutic applications of Cyanobacteria.
    Raja R; Hemaiswarya S; Ganesan V; Carvalho IS
    Crit Rev Microbiol; 2016 May; 42(3):394-405. PubMed ID: 25629310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.
    Bajpai VK; Shukla S; Kang SM; Hwang SK; Song X; Huh YS; Han YK
    Mar Drugs; 2018 May; 16(6):. PubMed ID: 29882898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health applications of bioactive compounds from marine microalgae.
    de Jesus Raposo MF; de Morais RM; de Morais AM
    Life Sci; 2013 Oct; 93(15):479-86. PubMed ID: 23994664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanobacteria-derived peptide antibiotics discovered since 2000.
    Xue Y; Zhao P; Quan C; Zhao Z; Gao W; Li J; Zu X; Fu D; Feng S; Bai X; Zuo Y; Li P
    Peptides; 2018 Sep; 107():17-24. PubMed ID: 30077717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal compounds from cyanobacteria.
    Shishido TK; Humisto A; Jokela J; Liu L; Wahlsten M; Tamrakar A; Fewer DP; Permi P; Andreote AP; Fiore MF; Sivonen K
    Mar Drugs; 2015 Apr; 13(4):2124-40. PubMed ID: 25871291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phycobiliproteins: A Novel Green Tool from Marine Origin Blue-Green Algae and Red Algae.
    Chandra R; Parra R; Iqbal HM
    Protein Pept Lett; 2017; 24(2):118-125. PubMed ID: 27491380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive compounds from cyanobacteria and microalgae: an overview.
    Singh S; Kate BN; Banerjee UC
    Crit Rev Biotechnol; 2005; 25(3):73-95. PubMed ID: 16294828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites.
    Nagarajan M; Maruthanayagam V; Sundararaman M
    J Appl Toxicol; 2012 Mar; 32(3):153-85. PubMed ID: 21910132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedicinals from the phytosymbionts of marine invertebrates: a molecular approach.
    Dunlap WC; Battershill CN; Liptrot CH; Cobb RE; Bourne DG; Jaspars M; Long PF; Newman DJ
    Methods; 2007 Aug; 42(4):358-76. PubMed ID: 17560324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications.
    Hassan S; Meenatchi R; Pachillu K; Bansal S; Brindangnanam P; Arockiaraj J; Kiran GS; Selvin J
    J Basic Microbiol; 2022 Sep; 62(9):999-1029. PubMed ID: 35014044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploitation of marine algae: biogenic compounds for potential antifouling applications.
    Bhadury P; Wright PC
    Planta; 2004 Aug; 219(4):561-78. PubMed ID: 15221382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contamination by Microcystis and microcystins of blue-green algae food supplements (BGAS) on the Italian market and possible risk for the exposed population.
    Vichi S; Lavorini P; Funari E; Scardala S; Testai E
    Food Chem Toxicol; 2012 Dec; 50(12):4493-9. PubMed ID: 23036452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosynthesis, phycochemical constituents, and pharmacological properties of cyanobacterium Oscillatoria sp.
    Bishoyi AK; Mandhata CP; Sahoo CR; Paidesetty SK; Padhy RN
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1347-1375. PubMed ID: 37712972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.
    Shah SAA; Akhter N; Auckloo BN; Khan I; Lu Y; Wang K; Wu B; Guo YW
    Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29125580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog.
    Bautista AC; Moore CE; Lin Y; Cline MG; Benitah N; Puschner B
    BMC Vet Res; 2015 Jun; 11():136. PubMed ID: 26087767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifouling potential of cyanobacteria: a mini-review.
    Dahms HU; Ying X; Pfeiffer C
    Biofouling; 2006; 22(5-6):317-27. PubMed ID: 17110355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically active substances produced by antarctic cryptoendolithic fungi.
    Ocampo-Friedmann R; Friedmann EI
    Antarct J US; 1993; 28(5):252-4. PubMed ID: 11539461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out in the green: biologically active metabolites produced by cyanobacteria.
    Gademann K
    Chimia (Aarau); 2011; 65(6):416-9. PubMed ID: 21797171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of light intensity, temperature and CO₂ concentration on growth and lipids in green algae and cyanobacteria.
    Shukla M; Tabassum R; Singh R; Dhar DW
    Indian J Exp Biol; 2016 Jul; 54(7):482-487. PubMed ID: 29466628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review Study on Macrolides Isolated from Cyanobacteria.
    Wang M; Zhang J; He S; Yan X
    Mar Drugs; 2017 Apr; 15(5):. PubMed ID: 28445442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.